GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells

NKG2D ligands play a relevant role in Natural Killer (NK) cell -mediated immune surveillance of multiple myeloma (MM). Different levels of regulation control the expression of these molecules at cell surface. A number of oncogenic proteins and miRNAs act as negative regulators of NKG2D ligand transc...

Full description

Bibliographic Details
Main Authors: Andrea Kosta, Abdelilah Mekhloufi, Lorenzo Lucantonio, Alessandra Zingoni, Alessandra Soriani, Marco Cippitelli, Angela Gismondi, Francesca Fazio, Maria Teresa Petrucci, Angela Santoni, Helena Stabile, Cinzia Fionda
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.942640/full
_version_ 1818002362489372672
author Andrea Kosta
Abdelilah Mekhloufi
Lorenzo Lucantonio
Alessandra Zingoni
Alessandra Soriani
Marco Cippitelli
Angela Gismondi
Francesca Fazio
Maria Teresa Petrucci
Angela Santoni
Angela Santoni
Angela Santoni
Helena Stabile
Cinzia Fionda
author_facet Andrea Kosta
Abdelilah Mekhloufi
Lorenzo Lucantonio
Alessandra Zingoni
Alessandra Soriani
Marco Cippitelli
Angela Gismondi
Francesca Fazio
Maria Teresa Petrucci
Angela Santoni
Angela Santoni
Angela Santoni
Helena Stabile
Cinzia Fionda
author_sort Andrea Kosta
collection DOAJ
description NKG2D ligands play a relevant role in Natural Killer (NK) cell -mediated immune surveillance of multiple myeloma (MM). Different levels of regulation control the expression of these molecules at cell surface. A number of oncogenic proteins and miRNAs act as negative regulators of NKG2D ligand transcription and translation, but the molecular mechanisms sustaining their basal expression in MM cells remain poorly understood. Here, we evaluated the role of the growth arrest specific 6 (GAS6)/TAM signaling pathway in the regulation of NKG2D ligand expression and MM recognition by NK cells. Our data showed that GAS6 as well as MERTK and AXL depletion in MM cells results in MICA downregulation and inhibition of NKG2D-mediated NK cell degranulation. Noteworthy, GAS6 derived from bone marrow stromal cells (BMSCs) also increases MICA expression at both protein and mRNA level in human MM cell lines and in primary malignant plasma cells. NF-kB activation is required for these regulatory mechanisms since deletion of a site responsive for this transcription factor compromises the induction of mica promoter by BMSCs. Accordingly, knockdown of GAS6 reduces the capability of BMSCs to activate NF-kB pathway as well as to enhance MICA expression in MM cells. Taken together, these results shed light on molecular mechanism underlying NKG2D ligand regulation and identify GAS6 protein as a novel autocrine and paracrine regulator of basal expression of MICA in human MM cells.
first_indexed 2024-04-14T03:45:49Z
format Article
id doaj.art-25869058e7b14f3b8801c581e1b362a1
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-14T03:45:49Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-25869058e7b14f3b8801c581e1b362a12022-12-22T02:14:17ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-07-011310.3389/fimmu.2022.942640942640GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cellsAndrea Kosta0Abdelilah Mekhloufi1Lorenzo Lucantonio2Alessandra Zingoni3Alessandra Soriani4Marco Cippitelli5Angela Gismondi6Francesca Fazio7Maria Teresa Petrucci8Angela Santoni9Angela Santoni10Angela Santoni11Helena Stabile12Cinzia Fionda13Department of Molecular Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Biomedical Engineering, Emory University, Atlanta, GA, United StatesDepartment of Molecular Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Molecular Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Molecular Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Molecular Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Molecular Medicine, Sapienza University of Rome, Rome, ItalyDivision of Hematology, Department of Translational Medicine and Precision, Sapienza University of Rome, Rome, ItalyDivision of Hematology, Department of Translational Medicine and Precision, Sapienza University of Rome, Rome, ItalyDepartment of Molecular Medicine, Sapienza University of Rome, Rome, ItalyIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed, Pozzilli, ItalyIstituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, ItalyDepartment of Molecular Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Molecular Medicine, Sapienza University of Rome, Rome, ItalyNKG2D ligands play a relevant role in Natural Killer (NK) cell -mediated immune surveillance of multiple myeloma (MM). Different levels of regulation control the expression of these molecules at cell surface. A number of oncogenic proteins and miRNAs act as negative regulators of NKG2D ligand transcription and translation, but the molecular mechanisms sustaining their basal expression in MM cells remain poorly understood. Here, we evaluated the role of the growth arrest specific 6 (GAS6)/TAM signaling pathway in the regulation of NKG2D ligand expression and MM recognition by NK cells. Our data showed that GAS6 as well as MERTK and AXL depletion in MM cells results in MICA downregulation and inhibition of NKG2D-mediated NK cell degranulation. Noteworthy, GAS6 derived from bone marrow stromal cells (BMSCs) also increases MICA expression at both protein and mRNA level in human MM cell lines and in primary malignant plasma cells. NF-kB activation is required for these regulatory mechanisms since deletion of a site responsive for this transcription factor compromises the induction of mica promoter by BMSCs. Accordingly, knockdown of GAS6 reduces the capability of BMSCs to activate NF-kB pathway as well as to enhance MICA expression in MM cells. Taken together, these results shed light on molecular mechanism underlying NKG2D ligand regulation and identify GAS6 protein as a novel autocrine and paracrine regulator of basal expression of MICA in human MM cells.https://www.frontiersin.org/articles/10.3389/fimmu.2022.942640/fullGAS6AXLMERTKMICANKG2D ligandmultiple myeloma
spellingShingle Andrea Kosta
Abdelilah Mekhloufi
Lorenzo Lucantonio
Alessandra Zingoni
Alessandra Soriani
Marco Cippitelli
Angela Gismondi
Francesca Fazio
Maria Teresa Petrucci
Angela Santoni
Angela Santoni
Angela Santoni
Helena Stabile
Cinzia Fionda
GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells
Frontiers in Immunology
GAS6
AXL
MERTK
MICA
NKG2D ligand
multiple myeloma
title GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells
title_full GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells
title_fullStr GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells
title_full_unstemmed GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells
title_short GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells
title_sort gas6 tam signaling pathway controls mica expression in multiple myeloma cells
topic GAS6
AXL
MERTK
MICA
NKG2D ligand
multiple myeloma
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.942640/full
work_keys_str_mv AT andreakosta gas6tamsignalingpathwaycontrolsmicaexpressioninmultiplemyelomacells
AT abdelilahmekhloufi gas6tamsignalingpathwaycontrolsmicaexpressioninmultiplemyelomacells
AT lorenzolucantonio gas6tamsignalingpathwaycontrolsmicaexpressioninmultiplemyelomacells
AT alessandrazingoni gas6tamsignalingpathwaycontrolsmicaexpressioninmultiplemyelomacells
AT alessandrasoriani gas6tamsignalingpathwaycontrolsmicaexpressioninmultiplemyelomacells
AT marcocippitelli gas6tamsignalingpathwaycontrolsmicaexpressioninmultiplemyelomacells
AT angelagismondi gas6tamsignalingpathwaycontrolsmicaexpressioninmultiplemyelomacells
AT francescafazio gas6tamsignalingpathwaycontrolsmicaexpressioninmultiplemyelomacells
AT mariateresapetrucci gas6tamsignalingpathwaycontrolsmicaexpressioninmultiplemyelomacells
AT angelasantoni gas6tamsignalingpathwaycontrolsmicaexpressioninmultiplemyelomacells
AT angelasantoni gas6tamsignalingpathwaycontrolsmicaexpressioninmultiplemyelomacells
AT angelasantoni gas6tamsignalingpathwaycontrolsmicaexpressioninmultiplemyelomacells
AT helenastabile gas6tamsignalingpathwaycontrolsmicaexpressioninmultiplemyelomacells
AT cinziafionda gas6tamsignalingpathwaycontrolsmicaexpressioninmultiplemyelomacells